Genolution Inc (225220)

Currency in KRW
2,090
-90(-4.13%)
Closed·
225220 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 6 days
Fair Value
Day's Range
2,0852,225
52 wk Range
1,9805,140
Key Statistics
Bid/Ask
2,090.00 / 2,125.00
Prev. Close
2,180
Open
2,225
Day's Range
2,085-2,225
52 wk Range
1,980-5,140
Volume
68.26K
Average Volume (3m)
136.89K
1-Year Change
-41.13%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
225220 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Genolution Inc Company Profile

Genolution Inc. manufactures and sells IVD products in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and dsRNA research for the prevention of breeding and extermination. The company offers Nextractor, an automatic extraction system for isolation of DNA or RNA from various samples; and FFPE, whole blood, buccal swab, RV, TB/NTM, STD, HPV, HBV, and CMV/EBV extraction kits, as well as rice, plant, and cell extraction kits. It also provides siRNA/shRNA synthesis service to inhibit gene expression and other gene related services; and long dsRNA synthesis service to inhibit gene expression by injecting RNA into various living organisms. The company was founded in 2006 and is based in Seoul, South Korea.

Compare 225220 to Peers and Sector

Metrics to compare
225220
Peers
Sector
Relationship
P/E Ratio
−4.2x−0.9x−0.5x
PEG Ratio
0.090.120.00
Price/Book
0.5x1.3x2.6x
Price / LTM Sales
4.8x2.6x3.2x
Upside (Analyst Target)
-26.7%45.7%
Fair Value Upside
Unlock12.1%8.6%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-115.00 / --
Revenue / Forecast
2.07B / --
EPS Revisions
Last 90 days

225220 Income Statement

FAQ

What Stock Exchange Does Genolution Trade On?

Genolution is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Genolution?

The stock symbol for Genolution is "225220."

What Is the Genolution Market Cap?

As of today, Genolution market cap is 37.76B.

What Is Genolution's Earnings Per Share (TTM)?

The Genolution EPS (TTM) is -495.05.

When Is the Next Genolution Earnings Date?

Genolution will release its next earnings report on 07 Aug 2025.

From a Technical Analysis Perspective, Is 225220 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Genolution Stock Split?

Genolution has split 3 times.

How Many Employees Does Genolution Have?

Genolution has 0 employees.

What is the current trading status of Genolution (225220)?

As of 02 Aug 2025, Genolution (225220) is trading at a price of 2,090.00, with a previous close of 2,180.00. The stock has fluctuated within a day range of 2,085.00 to 2,225.00, while its 52-week range spans from 1,980.00 to 5,140.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.